Kunthel By

604 total citations
20 papers, 429 citations indexed

About

Kunthel By is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Kunthel By has authored 20 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kunthel By's work include Chronic Lymphocytic Leukemia Research (5 papers), Statistical Methods and Bayesian Inference (3 papers) and Statistical Methods and Inference (3 papers). Kunthel By is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Statistical Methods and Bayesian Inference (3 papers) and Statistical Methods and Inference (3 papers). Kunthel By collaborates with scholars based in United States, Australia and Italy. Kunthel By's co-authors include Anne E. Sanders, Gary D. Slade, Luda Diatchenko, William Maixner, Vanessa Miller, Richard Pazdur, Rupert W. Leong, Flora Mulkey, Kelly J. Norsworthy and Ann T. Farrell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Kunthel By

20 papers receiving 413 citations

Peers

Countries citing papers authored by Kunthel By

Since Specialization

Citations

This map shows the geographic impact of Kunthel By's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunthel By with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunthel By more than expected).

Fields of papers citing papers by Kunthel By

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunthel By. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunthel By. The network helps show where Kunthel By may publish in the future.

Co-authorship network of co-authors of Kunthel By

This figure shows the co-authorship network connecting the top 25 collaborators of Kunthel By. A scholar is included among the top collaborators of Kunthel By based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunthel By. Kunthel By is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory (R/R) Indolent NHL: Results from the Phase 1 CaDAnCe-101 Study 2024 ·Blood ·Constantine S. Tam, Anna Maria Frustaci, Fontanet Bijou, (unknown), John F. Seymour, Masa Lasica, Herbert Eradat, (unknown), (unknown), Irina Mocanu, Xiangmei Chen, Kunthel By, (unknown), Daniel O. Persky, Amit Agarwal, Chan Y. Cheah	2
2	Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Results from the Phase 1 CaDAnCe-101 Study 2024 ·Blood ·Meghan C. Thompson, Ricardo Parrondo, Anna Maria Frustaci, John N. Allan, Paolo Ghia, Irina Mocanu, Constantine S. Tam, Judith Trotman, Inhye E. Ahn, Stephan Stilgenbauer, Lydia Scarfò, Xiangmei Chen, Kunthel By, (unknown), Daniel O. Persky, Amit Agarwal, John F. Seymour	14
3	Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory Waldenström Macroglobulinemia: Results from the Phase 1 CaDAnCe-101 Study 2024 ·Blood ·John F. Seymour, Constantine S. Tam, Chan Y. Cheah, Ricardo Parrondo, John N. Allan, Judith Trotman, Ranjana H. Advani, Herbert Eradat, Pier Luigi Zinzani, Masa Lasica, Steven P. Treon, Xiangmei Chen, Kunthel By, (unknown), Daniel O. Persky, Amit Agarwal, Anna Maria Frustaci	9
4	Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia 2023 ·Blood Advances ·Constantine S. Tam, Judith Trotman, Stephen Opat, J. C. Stern, Heather Allewelt, Kunthel By, William Novotny, Jane Huang, Alessandra Tedeschi	6
5	First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101) 2023 ·Blood ·John F. Seymour, Chan Y. Cheah, Ricardo Parrondo, Meghan C. Thompson, Don A. Stevens, Masa Lasica, Michael Wang, Abhijeet Kumar, Judith Trotman, (unknown), Wei Ding, Kunthel By, (unknown), Xiangmei Chen, (unknown), Jason C. Paik, Amit Agarwal, Constantine S. Tam	45
6	Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs). 2020 ·Journal of Clinical Oncology ·Paz J. Vellanki, Shanthi Marur, (unknown), Pallavi S. Mishra‐Kalyani, Kunthel By, Andrew T. Girvin, (unknown), Harpreet Singh, Patricia Keegan, Erin Larkins, (unknown), Richard Pazdur, Marc R. Theoret	6
7	FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia 2019 ·Clinical Cancer Research ·Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam, Luning Zhuang, Pedro L. Del Valle, Donna Przepiorka, Yuan Li Shen, Christopher M. Sheth, Chao Liu, Rupert W. Leong, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur	93
8	Analysis of early mortality in randomized clinical trials evaluating anti-PD-1/PD-L1 antibodies: A systematic analysis by the United States Food and Drug Administration (FDA). 2019 ·Journal of Clinical Oncology ·Flora Mulkey, Kunthel By, Marc R. Theoret, V. Ellen Maher, Richard Pazdur, Rajeshwari Sridhara	7
9	FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens 2019 ·Blood ·Bindu Kanapuru, Susan Jin, Kunthel By, (unknown), (unknown), Rajeshwari Sridhara, Nicole Gormley, Ann T. Farrell, Richard Pazdur	1
10	Entacapone and prostate cancer in Parkinson's disease patients: A large Veterans Affairs healthcare system study 2018 ·Parkinsonism & Related Disorders ·Jacqueline M. Major, (unknown), Francesca Cunningham, Kunthel By, Kwan Hur, (unknown), Rong Jiang, Gerald D. Podskalny, (unknown), Simone Pinheiro, Steven T. Bird, (unknown), David J. Graham	4
11	FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma 2018 ·Blood ·Bindu Kanapuru, Susan Jin, Kunthel By, Yuan Li Shen, (unknown), Nicole Gormley, Ann T. Farrell, Richard Pazdur	1
12	Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community 2017 ·Pharmacoepidemiology and Drug Safety ·Kunthel By, Jana McAninch, (unknown), Alex Secora, Cynthia Kornegay, Catherine S. Hwang, (unknown), Mark Levenson	9
13	Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study 2014 ·Pharmacoepidemiology and Drug Safety ·David J. Graham, Kunthel By, Stephen McKean, Andrew D. Mosholder, Cynthia Kornegay, Judith A. Racoosin, Jessica C. Young, Mark Levenson, Thomas MaCurdy, Chris Worrall, Jeffrey A. Kelman	12
14	ORTH: R and SAS software for regression models of correlated binary data based on orthogonalized residuals and alternating logistic regressions 2013 ·Computer Methods and Programs in Biomedicine ·Kunthel By, Bahjat F. Qaqish, John S. Preisser, Jamie Perin, Richard C. Zink	6
15	Role of Allostatic Load in Sociodemographic Patterns of Pain Prevalence in the U.S. Population 2012 ·Journal of Pain ·Gary D. Slade, Anne E. Sanders, Kunthel By	46
16	Deletion diagnostics for alternating logistic regressions 2012 ·Biometrical Journal ·John S. Preisser, Kunthel By, Jamie Perin, Bahjat F. Qaqish	5
17	Excess Risk of Temporomandibular Disorder Associated With Cigarette Smoking in Young Adults 2011 ·Journal of Pain ·Anne E. Sanders, William Maixner, Andrea G. Nackley, Luda Diatchenko, Kunthel By, Vanessa Miller, Gary D. Slade	36
18	Study Methods, Recruitment, Sociodemographic Findings, and Demographic Representativeness in the OPPERA Study 2011 ·Journal of Pain ·Gary D. Slade, Eric Bair, Kunthel By, Flora Mulkey, (unknown), Rebecca Rothwell, Maria Reynolds, Vanessa Miller, Yoly González, Sharon M. Gordon, Margarete Ribeiro-Dasilva, Pei Feng Lim, Joel D. Greenspan, (unknown), Roger B. Fillingim, Luda Diatchenko, William Maixner, (unknown), Charles Knott, Richard Ohrbach	125
19	A Simulation Experiment to Investigate the Distributional Behavior of Extreme Cook's Distance for GEE to Models with Contaminated Binary Responses 2008 ·Kunthel By, John S. Preisser, Bahjat F. Qaqish	1
20	Performance of One-Step Approximation Relative to Exact Cluster Cook's Distance for GEE 2008 ·John S. Preisser, Kunthel By, Bahjat F. Qaqish	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact